vitamin · for chronic fatigue
Vitamin D
Muscle cells carry vitamin D receptors, and low levels are linked with the inflammation that drives tiredness.
Say that in clinical terms
Vitamin D receptors are present in skeletal muscle mitochondria. Vitamin D supports mitochondrial function, reduces inflammatory cytokines (IL-6, TNF-alpha) that drive fatigue, and modulates neuromuscular function for energy production.
How strong is the research?
50 people with confirmed chronic fatigue took high-dose vitamin D for 6 months. Nothing improved.
2 papers read, 1 supporting, 1 against.
Who was studied: The cited paper does not match the claim. Other evidence tends to show benefit only where levels were low to begin with.
How much to take
daily with a fat-containing meal
2000–4000 IU
Test 25(OH)D levels. Fatigue is a hallmark symptom of vitamin D deficiency. Target 40-60 ng/mL.
Before you take it
- NIH ODS Tolerable Upper Intake Level (UL) for adults aged 19+ is 4,000 IU/day
- Drug interaction: thiazide diuretics combined with vitamin D3 increase risk of hypercalcemia by reducing urinary calcium excretion
- Drug interaction: anticonvulsants (phenobarbital, phenytoin) induce CYP enzymes that accelerate vitamin D catabolism, reducing circulating levels and therapeutic efficacy
- Drug interaction: bile acid sequestrants (cholestyramine, colestipol) impair absorption of fat-soluble vitamins including vitamin D3; doses should be separated
- Drug interaction: orlistat inhibits dietary fat absorption and reduces vitamin D3 absorption; monitoring of vitamin D status is recommended with concurrent use
- Drug interaction: corticosteroids (e.g., prednisone, dexamethasone) impair vitamin D metabolism and reduce intestinal calcium absorption, potentially antagonizing vitamin D effects
- Drug interaction: vitamin D3 at high doses may alter CYP3A4 activity and potentially affect pharmacokinetics of statins metabolized by that pathway (atorvastatin, lovastatin, simvastatin); clinical significance is modest
- Contraindication: pre-existing hypercalcemia or hypercalciuria — supplementation without medical supervision is contraindicated
- Caution: granulomatous diseases (sarcoidosis, tuberculosis, histoplasmosis, some lymphomas) produce unregulated endogenous calcitriol independent of serum 25(OH)D; exogenous vitamin D supplementation can precipitate severe hypercalcemia — requires endocrinology oversight
- Caution: impaired renal function reduces conversion of vitamin D to active calcitriol and impairs urinary calcium excretion, increasing toxicity risk; monitoring is required
- Caution: primary hyperparathyroidism — calcium-vitamin D axis is dysregulated; supplementation requires specialist oversight
- Toxicity signs at sustained supra-UL doses: hypercalcemia, hypercalciuria, nausea, polyuria, weakness, nephrolithiasis, soft-tissue calcification, and irreversible renal damage
When to take it
Best taken: morning